Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinkai Pharmaceutical is a leading Contract Development and Manufacturing Organization (CDMO) specializing in the development and commercial production of fluorine-containing small molecule intermediates and Active Pharmaceutical Ingredients (APIs). The company provides customized R&D and manufacturing services to global pharmaceutical, agrochemical, and specialty chemical companies, leveraging its expertise in complex fluorination chemistry. With multiple manufacturing sites in China and a presence in the United States, Jinkai supports drug candidates from early-stage development through to large-scale commercial launch. Its core competencies include high-pressure fluorination, chlorination, and other hazardous chemical reactions conducted under stringent quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalian Jinkai Technology Development.